SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: E_K_S who wrote (45943)12/13/2011 8:54:30 PM
From: Spekulatius  Read Replies (1) | Respond to of 78740
 
re COV I have done this several times, starting to average in the stock in the low 40's, averaging out around 50$. The company has become more valuable over time, mid-high single digit growth, ~1.8B$ in FCF (before acquisitions), good balance sheet and a small 2% dividend.

the company has improved their metrice, gross margins went from the low 50's to the high 50's % range, this is partly invested in R&D (Tyco was skimpy with R&D, so their products were stale when COV was spun off). I believe COV management is doing a good job executing to plan. It is imo a company that WEB may like.

I may get this cheaper (based on charts) or I may not. I believe right now it's as good of a buy in terms of valuation as it has ever been. I am happy to buy more in the high 30's if it get there.

I never get the cheapest price on this stock and never went out at the top, I always bought to early and sold to early, but I always made money holding COV.



To: E_K_S who wrote (45943)12/13/2011 11:37:58 PM
From: Paul Senior  Read Replies (1) | Respond to of 78740
 
Heathcare buying range: I may add to my few shares of ZMH and GILD if/as these stocks drop further

finance.yahoo.com